bioMérieux

bioMérieux

Recherche en biotechnologie

Marcy-l'Étoile, Auvergne-Rhône-Alpes 335 314 abonnés

Pioneering Diagnostics

À propos

Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP

Secteur
Recherche en biotechnologie
Taille de l’entreprise
+ de 10 000 employés
Siège social
Marcy-l'Étoile, Auvergne-Rhône-Alpes
Type
Société cotée en bourse
Fondée en
1963
Domaines
in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank et sepsis

Lieux

Employés chez bioMérieux

Nouvelles

Pages affiliées

Pages similaires

Parcourir les offres d’emploi